Incannex Healthcare Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IXHL research report →
Companywww.incannex.com.au
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases.
- CEO
- Joel Bradley Latham
- IPO
- 2022
- Employees
- 9
- HQ
- Sydney, NSW, AU
Price Chart
Valuation
- Market Cap
- $42.61M
- P/E
- -0.78
- P/S
- 495.45
- P/B
- 0.59
- EV/EBITDA
- 0.45
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -37921.41%
- Net Margin
- -64630.36%
- ROE
- -190.00%
- ROIC
- -44.33%
Growth & Income
- Revenue
- $86.00K · 378.70%
- Net Income
- $-46,885,000 · -69.66%
- EPS
- $-40.80 · -1092.98%
- Op Income
- $-23,789,000
- FCF YoY
- 22.34%
Performance & Tape
- 52W High
- $49.80
- 52W Low
- $2.49
- 50D MA
- $3.66
- 200D MA
- $9.74
- Beta
- 2.87
- Avg Volume
- 561.02K
Get TickerSpark's AI analysis on IXHL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 14, 25 | Valentine Troy | other | 11,302,608 |
| Nov 14, 25 | Clark Robert | other | 1,686,956 |
| Nov 14, 25 | Widdows Peter | other | 1,686,956 |
| Nov 14, 25 | Swan Joseph | other | 869,565 |
| Nov 14, 25 | Latham Joel | other | 22,608,692 |
| Nov 14, 25 | Anastassov George | other | 1,686,956 |
| Oct 23, 24 | Barbato Luigi M. | other | 100,476 |
| Oct 21, 24 | Barbato Luigi M. | other | 0 |
| Jun 30, 24 | Swan Joseph | other | 0 |
| Dec 21, 23 | Valentine Troy | other | 670,000 |
Our IXHL Coverage
We haven't published any research on IXHL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IXHL Report →